Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins

Oncogene volume 23, pages 3338–3349 (2004)Cite this article

Abstract

In about 30% of the patients with acute myeloid leukemia, activating FLT3 receptor mutations have been identified, often as in-frame internal tandem duplications (ITD) at the juxtamembrane domain of the receptor. FLT3-ITD receptors exhibit constitutive tyrosine kinase activity in the absence of FLT3 ligand (FL) binding, and when expressed in cytokine-dependent cell lines and primary hematopoietic cells suppress programmed cell death and increase cell division. However, the signaling pathways important for transformation, in particular the nuclear targets, are unknown. Here we demonstrate that FLT3-ITD expression in Ba/F3 cells results in activation of Akt and concomitant phosphorylation of the Forkhead family member Foxo3a. Phosphorylation of Foxo proteins through FLT3-ITD signaling promotes their translocation from the nucleus into the cytoplasm, which requires the presence of conserved Akt phosphorylation sites in Forkhead transcription factors and PI3K activity. Induction of Foxo3a phosphorylation by FLT3-ITD receptors in Ba/F3 cells correlates with the suppression of Foxo-target genes p27Kip1 and the proapoptotic Bcl-2 family member Bim. Specifically, FLT3-ITD expression prevents Foxo3a-mediated apoptosis and upregulation of p27Kip1 and Bim gene expression. These data indicate that the oncogenic tyrosine kinase FLT3 can negatively regulate Foxo transcription factors, thereby promoting cell survival and proliferation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Abu-Duhier FM, Goodeve AC, Wilson GA, Care RS, Peake IR and Reilly JT . (2001). Br. J. Haematol., 113, 983–988.

  • Alvarez B, Martinez AC, Burgering BM and Carrera AC . (2001). Nature, 413, 744–747.

  • Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR and Korsmeyer SJ . (2002). Nat. Genet., 30, 41–47.

  • Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F, Adams JM and Strasser A . (1999). Science, 286, 1735–1738.

  • Brownawell AM, Kops GJ, Macara IG and Burgering BM . (2001). Mol. Cell. Biol., 21, 3534–3546.

  • Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME . (1999). Cell, 96, 857–868.

  • Brunet A, Park J, Tran H, Hu LS, Hemmings BA and Greenberg ME . (2001). Mol. Cell. Biol., 21, 952–965.

  • Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S and Reed JC . (1998). Science, 282, 1318–1321.

  • Carow CE, Levenstein M, Kaufmann SH, Chen J, Amin S, Rockwell P, Witte L, Borowitz MJ, Civin CI and Small D . (1996). Blood, 87, 1089–1096.

  • Castrillon DH, Miao L, Kollipara R, Horner JW and DePinho RA . (2003). Science, 301, 215–218.

  • DaSilva N, Hu ZB, Ma W, Rosnet O, Birnbaum D and Drexler HG . (1994). Leukemia, 8, 885–888.

  • Datta K, Bellacosa A, Chan TO and Tsichlis PN . (1996). J. Biol. Chem., 271, 30835–30839.

  • Datta SR, Brunet A and Greenberg ME . (1999). Genes Dev., 13, 2905–2927.

  • De Ruiter ND, Burgering BM and Bos JL . (2001). Mol. Cell. Biol., 21, 8225–8235.

  • del Peso L, Gonzalez-Garcia M, Page C, Herrera R and Nunez G . (1997). Science, 278, 687–689.

  • Dierov J, Xu Q, Dierova R and Carroll M . (2002). Blood, 99, 1758–1765.

  • Dijkers PF, Birkenkamp KU, Lam EW, Thomas NS, Lammers JW, Koenderman L and Coffer PJ . (2002). J. Cell. Biol., 156, 531–542.

  • Dijkers PF, Medema RH, Lammers JW, Koenderman L and Coffer PJ . (2000a). Curr. Biol., 10, 1201–1204.

  • Dijkers PF, Medema RH, Pals C, Banerji L, Thomas NS, Lam EW, Burgering BM, Raaijmakers JA, Lammers JW, Koenderman L and Coffer PJ . (2000b). Mol. Cell. Biol., 20, 9138–9148.

  • Engstrom M, Karlsson R and Jonsson JI . (2003). Exp. Hematol., 31, 316–323.

  • Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR and Tsichlis PN . (1995). Cell, 81, 727–736.

  • Gilliland DG and Griffin JD . (2002). Blood, 100, 1532–1542.

  • Harris CA and Johnson Jr EM . (2001). J. Biol. Chem., 276, 37754–37760.

  • Hayakawa F, Towatari M, Kiyoi H, Tanimoto M, Kitamura T, Saito H and Naoe T . (2000). Oncogene, 19, 624–631.

  • Kaestner KH, Knochel W and Martinez DE . (2000). Genes Dev., 14, 142–146.

  • Kashii Y, Uchida M, Kirito K, Tanaka M, Nishijima K, Toshima M, Ando T, Koizumi K, Endoh T, Sawada K, Momoi M, Miura Y, Ozawa K and Komatsu N . (2000). Blood, 96, 941–949.

  • Kelly LM, Liu Q, Kutok JL, Williams IR, Boulton CL and Gilliland DG . (2002). Blood, 99, 310–318.

  • Klucher KM, Lopez DV and Daley GQ . (1998). Blood, 91, 3927–3934.

  • Komatsu N, Watanabe T, Uchida M, Mori M, Kirito K, Kikuchi S, Liu Q, Tauchi T, Miyazawa K, Endo H, Nagai T and Ozawa K . (2003). J. Biol. Chem., 278, 6411–6419.

  • Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL and Burgering BM . (1999). Nature, 398, 630–634.

  • Kops GJ, Medema RH, Glassford J, Essers MA, Dijkers PF, Coffer PJ, Lam EW and Burgering BM . (2002). Mol. Cell. Biol., 22, 2025–2036.

  • Lawlor MA and Alessi DR . (2001). J. Cell. Sci., 114, 2903–2910.

  • Levis M, Allebach J, Tse KF, Zheng R, Baldwin BR, Smith BD, Jones-Bolin S, Ruggeri B, Dionne C and Small D . (2002). Blood, 99, 3885–3891.

  • Li H, Zhu H, Xu CJ and Yuan J . (1998). Cell, 94, 491–501.

  • Liu D, Yang X and Songyang Z . (2000). Curr. Biol., 10, 1233–1236.

  • Lyman SD and Jacobsen SE . (1998). Blood, 91, 1101–1134.

  • Medema RH, Kops GJ, Bos JL and Burgering BM . (2000). Nature, 404, 782–787.

  • Meierhoff G, Dehmel U, Gruss HJ, Rosnet O, Birnbaum D, Quentmeier H, Dirks W and Drexler HG . (1995). Leukemia, 9, 1368–1372.

  • Minami Y, Yamamoto K, Kiyoi H, Ueda R, Saito H and Naoe T . (2003). Blood, 102, 2969–2975.

  • Mizuki M, Fenski R, Halfter H, Matsumura I, Schmidt R, Muller C, Gruning W, Kratz-Albers K, Serve S, Steur C, Buchner T, Kienast J, Kanakura Y, Berdel WE and Serve H . (2000). Blood, 96, 3907–3914.

  • Modur V, Nagarajan R, Evers BM and Milbrandt J . (2002). J. Biol. Chem., 277, 47928–47937.

  • Nakae J, Barr V and Accili D . (2000). EMBO J., 19, 989–996.

  • Nakae J, Biggs III WH, Kitamura T, Cavenee WK, Wright CV, Arden KC and Accili D . (2002). Nat. Genet., 32, 245–253.

  • Nakae J, Kitamura T, Kitamura Y, Biggs WH, Arden KC and Accili D . (2003). Dev. Cell, 4, 119–129.

  • Nakae J, Kitamura T, Ogawa W, Kasuga M and Accili D . (2001). Biochemistry, 40, 11768–11776.

  • Nakao M, Yokota S, Iwai T, Kaneko H, Horiike S, Kashima K, Sonoda Y, Fujimoto T and Misawa S . (1996). Leukemia, 10, 1911–1918.

  • O'Connor L, Strasser A, O'Reilly LA, Hausmann G, Adams JM, Cory S and Huang DC . (1998). EMBO J., 17, 384–395.

  • Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbaum HA and Ruvkun G . (1997). Nature, 389, 994–999.

  • Parada Y, Banerji L, Glassford J, Lea NC, Collado M, Rivas C, Lewis JL, Gordon MY, Thomas NS and Lam EW . (2001). J. Biol. Chem., 276, 23572–23580.

  • Paradis S and Ruvkun G . (1998). Genes Dev., 12, 2488–2498.

  • Ramaswamy S, Nakamura N, Sansal I, Bergeron L and Sellers WR . (2002). Cancer Cell., 2, 81–91.

  • Rena G, Guo S, Cichy SC, Unterman TG and Cohen P . (1999). J. Biol. Chem., 274, 17179–17183.

  • Rena G, Prescott AR, Guo S, Cohen P and Unterman TG . (2001). Biochem. J., 354, 605–612.

  • Rena G, Woods YL, Prescott AR, Peggie M, Unterman TG, Williams MR and Cohen P . (2002). EMBO J., 21, 2263–2271.

  • Rokudai S, Fujita N, Kitahara O, Nakamura Y and Tsuruo T . (2002). Mol. Cell. Biol., 22, 8695–8708.

  • Rosnet O, Marchetto S, deLapeyriere O and Birnbaum D . (1991). Oncogene, 6, 1641–1650.

  • Rosnet O, Schiff C, Pebusque MJ, Marchetto S, Tonnelle C, Toiron Y, Birg F and Birnbaum D . (1993). Blood, 82, 1110–1119.

  • Scheid MP, Marignani PA and Woodgett JR . (2002). Mol. Cell. Biol., 22, 6247–6260.

  • Scheijen B and Griffin JD . (2002). Oncogene, 21, 3314–3333.

  • Schmidt M, de Mattos SF, van der Horst A, Klompmaker R, Kops GJ, Lam EW, Burgering BM and Medema RH . (2002). Mol. Cell. Biol., 22, 7842–7852.

  • Shinjyo T, Kuribara R, Inukai T, Hosoi H, Kinoshita T, Miyajima A, Houghton PJ, Look AT, Ozawa K and Inaba T . (2001). Mol. Cell. Biol., 21, 854–864.

  • Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK, Trotta R, Wlodarski P, Perrotti D, Chan TO, Wasik MA, Tsichlis PN and Calabretta B . (1997). EMBO J., 16, 6151–6161.

  • Spiekermann K, Bagrintseva K, Schoch C, Haferlach T, Hiddemann W and Schnittger S . (2002). Blood, 100, 3423–3425.

  • Spiekermann K, Bagrintseva K, Schwab R, Schmieja K and Hiddemann W . (2003). Clin. Cancer Res., 9, 2140–2150.

  • Stahl M, Dijkers PF, Kops GJ, Lens SM, Coffer PJ, Burgering BM and Medema RH . (2002). J. Immunol., 168, 5024–5031.

  • Tanaka M, Kirito K, Kashii Y, Uchida M, Watanabe T, Endo H, Endoh T, Sawada K, Ozawa K and Komatsu N . (2001). J. Biol. Chem., 276, 15082–15089.

  • Tang ED, Nunez G, Barr FG and Guan KL . (1999). J. Biol. Chem., 274, 16741–16746.

  • Thiede C, Steudel C, Mohr B, Schaich M, Schakel U, Platzbecker U, Wermke M, Bornhauser M, Ritter M, Neubauer A, Ehninger G and Illmer T . (2002). Blood, 99, 4326–4335.

  • Toyoshima H and Hunter T . (1994). Cell, 78, 67–74.

  • U M, Miyashita T, Shikama Y, Tadokoro K and Yamada M . (2001). FEBS Lett., 509, 135–141.

  • Uddin S, Kottegoda S, Stigger D, Platanias LC and Wickrema A . (2000). Biochem. Biophys. Res. Commun., 275, 16–19.

  • Villunger A, Scott C, Bouillet P and Strasser A . (2003). Blood, 101, 2393–2400.

  • Weisberg E, Boulton C, Kelly LM, Manley P, Fabbro D, Meyer T, Gilliland DG and Griffin JD . (2002). Cancer Cell, 1, 433–443.

  • Whitfield J, Neame SJ, Paquet L, Bernard O and Ham J . (2001). Neuron, 29, 629–643.

  • Williamson EA, Dadmanesh F and Koeffler HP . (2002). Oncogene, 21, 3199–3206.

  • Woods YL, Rena G, Morrice N, Barthel A, Becker W, Guo S, Unterman TG and Cohen P . (2001). Biochem. J., 355, 597–607.

  • Yamamoto Y, Kiyoi H, Nakano Y, Suzuki R, Kodera Y, Miyawaki S, Asou N, Kuriyama K, Yagasaki F, Shimazaki C, Akiyama H, Saito K, Nishimura M, Motoji T, Shinagawa K, Takeshita A, Saito H, Ueda R, Ohno R and Naoe T . (2001). Blood, 97, 2434–2439.

  • Yang W, Shen J, Wu M, Arsura M, FitzGerald M, Suldan Z, Kim DW, Hofmann CS, Pianetti S, Romieu-Mourez R, Freedman LP and Sonenshein GE . (2001). Oncogene, 20, 1688–1702.

  • Zhang S, Fukuda S, Lee Y, Hangoc G, Cooper S, Spolski R, Leonard WJ and Broxmeyer HE . (2000). J. Exp. Med., 192, 719–728.

  • Zhao M, Kiyoi H, Yamamoto Y, Ito M, Towatari M, Omura S, Kitamura T, Ueda R, Saito H and Naoe T . (2000). Leukemia, 14, 374–378.

  • Zheng R, Friedman AD and Small D . (2002). Blood, 100, 4154–4161.

Download references

Acknowledgements

We wish to thank Tomoki Naoe, William Sellers and George Daley for reagents. This work was supported by a Leukemia and Lymphoma Society SCOR grant and NIH grant R01 CA66996. BS is the recipient of a Fellowship of the Dutch Cancer Society (KWF/NKB).

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Dana-Farber Cancer Institute, Mayer 540, 44 Binney Street, Boston, 02115, MA, USA

    Blanca Scheijen, Hai T Ngo, Hyun Kang & James D Griffin

  2. Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Mayer 540, 44 Binney Street, Boston, 02115, MA, USA

    Blanca Scheijen, Hai T Ngo, Hyun Kang & James D Griffin

Authors
  1. Blanca Scheijen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hai T Ngo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hyun Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. James D Griffin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James D Griffin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scheijen, B., Ngo, H., Kang, H. et al. FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins. Oncogene 23, 3338–3349 (2004). https://doi.org/10.1038/sj.onc.1207456

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207456

Keywords

This article is cited by

Search

Advanced search

Quick links